#Polygenic risk scores have made progress towards viable clinical applications over 2024, particularly w/resp to #cardiovascular disease, while evidence for the clinical utility of embryo PRS testing remains insufficient. My latest for GenomeWeb http://drupal.prod.genomeweb.com/genetic-research/polygenic-risk-scores-inch-towards-clinical-use-2024
Comments